Serum neurotransmitter analysis of motor and non-motor symptoms in Parkinson’s patients DOI Creative Commons
Yichun Fan,

Wenping Yang,

Weilan Wu

и другие.

Frontiers in Aging Neuroscience, Год журнала: 2024, Номер 16

Опубликована: Ноя. 25, 2024

Clinical symptoms of Parkinson’s disease (PD) are classified into motor and non-motor symptoms. Mental disorders, especially depression, one the major manifestations PD. However, underlying mechanisms remain poorly understood. In present study, 21 neurotransmitters associated with mental disorders were measured in serum samples from patients controls using ultra-high performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS) assay. Additionally, five clinical scales—the MDS Unified Disease Rating Scale (UPDRS), Non-Motor Symptoms (NMSS), Mini-Mental State Examination (MMSE), Hamilton Anxiety (HAMA), Depression (HAMD)—were used to evaluate severity both PD patients. Analysis neurotransmitter metabolism revealed significant changes tryptophan (Trp) metabolic pathway Specifically, levels Trp, kynurenine (KYN), kynurenic acid (KA), nicotinamide (NAM), 5-methoxyltryptamine (MeOTA) substantially decreased. three other excitation/inhibiting amino acids—glutamic (Glu), 4-aminobutyric (GABA), aspartic (Asp)—also declined. Moreover, conversion ratios, such as KA/KYN, nicotinamide/niacin (NAM/NA), 5-hydroxytryptophan/tryptophan (5-HTP/Trp), quinolinic acid/kynurenic (QA/KA), provided more dynamic insights disrupted metabolism. Correlation analyses between scale scores showed that concentrations xanthurenic (XA) turnover rate 3-hydroxykynurenine (3-HK) negatively correlated UPDRS scores, while 5-hydroxytryptamine (5-HT) GABA summary, this study elucidates, for first time, potential association dynamics altered etiology terms functions. These findings offer novel biomarkers therapeutic targets treatment

Язык: Английский

Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit DOI Creative Commons

Bandar Alharbi,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

European journal of medical research, Год журнала: 2024, Номер 29(1)

Опубликована: Март 27, 2024

Abstract Parkinson's disease (PD) is a progressive neurodegenerative as result of the degeneration dopaminergic neurons in substantia nigra pars compacta (SNpc). The fundamental features PD are motor and non-motor symptoms. symptoms develop due to disruption neurotransmitters other such γ-aminobutyric acid (GABA). potential role GABA neuropathology concerning was not precisely discussed. Therefore, this review intended illustrate possible regarding pathway essential regulating inhibitory tone prevent excessive stimulation cerebral cortex. Degeneration linked with reducing GABAergic neurotransmission. Decreasing activity promotes mitochondrial dysfunction oxidative stress, which highly related neuropathology. Hence, restoring by agonists may attenuate progression dysregulation SNpc contributes developing Besides, also pathway, amelioration reduce In conclusion, deregulation might be intricate Improving novel, beneficial approach control

Язык: Английский

Процитировано

16

Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue DOI Creative Commons
Areej Turkistani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Molecular Neurobiology, Год журнала: 2024, Номер 61(9), С. 7092 - 7108

Опубликована: Фев. 17, 2024

Abstract Parkinson’s disease (PD) is a progressive neurodegenerative of the brain due to degeneration dopaminergic neurons in substantia nigra (SN). Glycogen synthase kinase 3 beta (GSK-3β) implicated pathogenesis PD. Therefore, purpose present review was revise mechanistic role GSK-3β PD neuropathology, and how inhibitors affect neuropathology. GSK-3 conserved threonine/serine protein that intricate regulation cellular anabolic catabolic pathways by modulating glycogen synthase. Over-expression also interconnected with development different diseases. However, underlying mechanism neuropathology not fully clarified. induces triggering mitochondrial dysfunction oxidative stress SN. NF-κB NLRP3 inflammasome are activated response dysregulated leading neuronal injury. Higher expression early stages might contribute reduction neuroprotective brain-derived neurotrophic factor (BDNF). Thus, may be effective reducing inflammatory disorders which associated

Язык: Английский

Процитировано

12

Defective autophagy and autophagy activators in myasthenia gravis: a rare entity and unusual scenario DOI
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Majid S. Jabir

и другие.

Autophagy, Год журнала: 2024, Номер 20(7), С. 1473 - 1482

Опубликована: Фев. 12, 2024

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction (NMJ) that results from autoantibodies against nicotinic acetylcholine receptors (nAchRs) at NMJs. These are mainly originated autoreactive B cells bind and destroy nAchRs NMJs preventing nerve impulses activating end-plates skeletal muscle. Indeed, immune dysregulation plays a crucial role in pathogenesis MG. Autoreactive increased MG due to defect central peripheral tolerance mechanisms. As well, T augmented diversion regulatory (T

Язык: Английский

Процитировано

11

The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon DOI
Hayder M. Al‐kuraishy,

Sadiq M. Al‐Hamash,

Majid S. Jabir

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 94, С. 102200 - 102200

Опубликована: Янв. 17, 2024

Язык: Английский

Процитировано

10

Role of fenofibrate in multiple sclerosis DOI Creative Commons
Ahmad Abulaban, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

European journal of medical research, Год журнала: 2024, Номер 29(1)

Опубликована: Фев. 9, 2024

Abstract Multiple sclerosis (MS) is the most frequent inflammatory and demyelinating disease of central nervous system (CNS). The underlying pathophysiology MS destruction myelin sheath by immune cells. formation plaques, inflammation, injury neuronal characterizes its neuropathology. plaques are multiple focal regions demyelination disseminated in brain's white matter, spinal cords, deep grey cerebral cortex. Fenofibrate a peroxisome proliferative activated receptor alpha (PPAR-α) that attenuates reactions MS. inhibits differentiation Th17 inhibiting expression pro-inflammatory signaling. According to these findings, this review intended illuminate mechanistic immunoinflammatory role fenofibrate mitigating In conclusion, can attenuate neuropathology modulating different pathways, including oxidative stress, autophagy, mitochondrial dysfunction, inflammatory-signaling neuroinflammation.

Язык: Английский

Процитировано

9

Irisin's emerging role in Parkinson's disease research: A review from molecular mechanisms to therapeutic prospects DOI Creative Commons

Ruqing Qiu,

Weilu Sun,

Yana Su

и другие.

Life Sciences, Год журнала: 2024, Номер 357, С. 123088 - 123088

Опубликована: Сен. 30, 2024

Язык: Английский

Процитировано

4

Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet DOI Creative Commons
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

European Journal of Pharmacology, Год журнала: 2025, Номер unknown, С. 177419 - 177419

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

The role of irisin in exercise-induced muscle and metabolic health: a narrative review DOI

Sumaya Nadhim Mohammed,

Mohannad Hamid Jasim,

Shahad Hisham Mahmood

и другие.

Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2025, Номер unknown

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Glutamatergic dysfunction in neurodegenerative diseases focusing on Parkinson's disease: Role of glutamate modulators DOI Creative Commons
Najlaa H. Almohmadi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Brain Research Bulletin, Год журнала: 2025, Номер unknown, С. 111349 - 111349

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Plasma BDNF/Irisin Ratio Associates with Cognitive Function in Older People DOI
Xiuxiu Huang, Jiaxin Wang, Shifang Zhang

и другие.

Journal of Alzheimer s Disease, Год журнала: 2024, Номер 99(4), С. 1261 - 1271

Опубликована: Май 23, 2024

Background: Reliable blood biomarkers are crucial for early detection and treatment evaluation of cognitive impairment, including Alzheimer’s disease other dementias. Objective: To examine whether plasma their combination different between older people with mild impairment (MCI) cognitively normal individuals, to explore relations performance. Methods: This cross-sectional study included 250 adults, 124 participants MCI, 126 participants. Plasma brain-derived neurotrophic factor (BDNF), irisin clusterin were measured, BDNF/irisin ratio was calculated. Global cognition evaluated by the Montreal Cognitive Assessment. Results: levels, but not BDNF, significantly MCI group group. Higher concentration associated an increased probability both before after controlling covariates. By contrast, BDNF concentration, irisin, linearly correlated performance adjusting ratios only better performance, also lower risks no matter we adjusted concentrations aging, whereas remained stable. No significant results observed. Conclusions: may be a reliable indicator which reflects odds presence directly associates

Язык: Английский

Процитировано

3